GlassScriptPhysician profile
Carrie Pearson
NPI 1992923957
$1,855.57
in general payments reported to CMS, 2019-2025
19 companies · $855 in 2025
The $855 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $41.65 · 2023: $216 · 2024: $537 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481 · Travel and Lodging: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,480.85 |
| Travel and Lodging | $127.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $429.52 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Atricure, INC. | $388.42 | 2021-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Baxter Healthcare | $188.03 | 2022-2024 | Starling System |
| Solventum Corporation | $162.88 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Edwards Lifesciences Corporation | $147.02 | 2021-2023 | Mitris Resilia Mitral Valve |
| Medical Device Business Services, INC. | $124.09 | 2024 | Vistaseal |
| Abiomed | $100.68 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $45.34 | 2023 | |
| Medtronic, INC. | $44.11 | 2025 | Avalus, Penditure |
| Boston Scientific Corporation | $39.92 | 2023 | Watchman Flx |
| Scpharmaceuticals INC. | $28.41 | 2024 | |
| Davol INC. | $27.05 | 2025 | Arista |
| La Jolla Pharmaceutical Company | $24.14 | 2025 | Giapreza |
| Merck Sharp & Dohme LLC | $21.30 | 2025 | Verquvo |
| Kls-Martin L.P. | $20.14 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $17.34 | 2023 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.04 | 2025 | Lifevest |
| Amgen INC. | $15.57 | 2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $14.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.